Does hyperandrogenic statute in the polycystic ovary syndrome constitute an obstacle to the success of in vitro fertilization?

被引:5
|
作者
Gaddas, M. [1 ]
Chaouache, N. [1 ]
Ajina, M. [2 ]
Tabka, Z. [1 ]
Ajina, M. Zaouali [1 ]
机构
[1] Fac Med Ibn el Jazzar, Lab Physiol & Explorat Fonct, Ave Mohamed Karoui, Sousse 4000, Tunisia
[2] CHU Farhat Hached, Unite Med Reprod, Ave Ibn el Jazzar, Sousse 4000, Tunisia
来源
JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION | 2016年 / 45卷 / 09期
关键词
Hyperandrogenism; IVF; Polycystic ovarian; syndrome; SYNDROME PCOS; ANDROGEN RECEPTORS; INSULIN-RESISTANCE; DOWN-REGULATION; WOMEN; TESTOSTERONE; CYCLES; CELL; STIMULATION; APOPTOSIS;
D O I
10.1016/j.jgyn.2016.08.007
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives. The aim of this study was to evaluate the impact of initial androgenic statute of women with polycystic ovary syndrome (SOPK) on the expected results of in vitro fertilization (FIV). Materials and methods. It is about an exploratory study carried out in 61 unfertile SOPK patients, having profited all from a cycle of FIV/ICSI (intracytoplasmic sperm injection). We have divided our population in two groups according to their hormonal androgenic statute: groups with hyperandrogenism and without hyperandrogenism. We proceeded to note the anthropometric and hormonal parameters as well as results of FIV for each of the two groups. Results. SOPK patients with hyperandrogenism are more obese than their counterparts. Also, they have more oocytes collected after ovarian induction. In addition, we did not reveal any significant differences between our two study groups concerning parameters defining FIV response. Conclusion. Our findings suggest that hyperandrogenism statute in SOPK infertile women does not seem to compromise the results of FIV. On the contrary, it would make it possible to optimize the chances to puncture more significant number of oocytes. (C) 2016 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1091 / 1098
页数:8
相关论文
共 50 条
  • [41] Outcomes of the Next In Vitro Fertilization Cycle in Women with Polycystic Ovary Syndrome after a Failed In Vitro Maturation Attempt
    Guo, Wei
    Xu, Yalan
    Tian, Tian
    Yang, Shuo
    Li, Rong
    Qiao, Jie
    Zheng, Xiaoying
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (17)
  • [42] Obstetric outcomes in women with polycystic ovary syndrome and isolated polycystic ovaries undergoing in vitro fertilization: a retrospective cohort analysis
    Wan, Hei Lok Tiffany
    Hui, Pui Wah
    Li, Hang Wun Raymond
    Ng, Ernest Hung Yu
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2015, 28 (04) : 475 - 478
  • [43] Insulin Resistant Phenotype of Polycystic Ovary Syndrome does not Seem to be Caused by Variation in FTO
    Hatziagelaki, E.
    Wagner, R.
    Kantartzis, K.
    Heni, M.
    Linder, K.
    Ketterer, C.
    Machicao, F.
    Stefan, N.
    Staiger, H.
    Haering, H. U.
    Fritsche, A.
    HORMONE AND METABOLIC RESEARCH, 2012, 44 (11) : 810 - 813
  • [44] Does alpha-1-acid glycoprotein determine for infertility in polycystic ovary syndrome?
    Durmus, Merve
    Uzunlar, Ozlem
    celik, Humeyra
    candar, Tuba
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2022, 274 : 155 - 159
  • [45] Polycystic ovary syndrome does not affect blastulation nor cumulative live birth rates
    Delaroche, L.
    Dupont, C.
    Oger, P.
    Aubriot, F-X
    Lamazou, F.
    Yazbeck, C.
    GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2019, 47 (09): : 655 - 661
  • [46] Gonadotrophin-releasing hormone-antagonists vs long agonist in in-vitro fertilization patients with polycystic ovary syndrome: a meta-analysis
    Mancini, Fulvia
    Tur, Rosa
    Martinez, Francisca
    Coroleu, Buenaventura
    Rodriguez, Ignacio
    Barri, Pedro N.
    GYNECOLOGICAL ENDOCRINOLOGY, 2011, 27 (03) : 150 - 155
  • [47] Metformin administration in patients with polycystic ovary syndrome who receive gonadotropins for in vitro fertilization cycles: 10-year experience in a large infertile population
    Palomba, Stefano
    Falbo, Angela
    Russo, Tiziana
    Di Cello, Annalisa
    Morelli, Michele
    Orio, Francesco
    Cappiello, Fulvio
    Tolino, Achille
    Zullo, Fulvio
    GYNECOLOGICAL ENDOCRINOLOGY, 2012, 28 (02) : 81 - 86
  • [48] Characterization of Reproductive, Metabolic, and Endocrine Features of Polycystic Ovary Syndrome in Female Hyperandrogenic Mouse Models
    Caldwell, A. S. L.
    Middleton, L. J.
    Jimenez, M.
    Desai, R.
    McMahon, A. C.
    Allan, C. M.
    Handelsman, D. J.
    Walters, K. A.
    ENDOCRINOLOGY, 2014, 155 (08) : 3146 - 3159
  • [49] Polycystic ovary syndrome phenotype does not have impact on oocyte morphology
    Uk, Audrey
    Decanter, Christine
    Grysole, Camille
    Keller, Laura
    Behal, Helene
    Silva, Mauro
    Dewailly, Didier
    Robin, Geoffroy
    Barbotin, Anne-Laure
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2022, 20 (01)
  • [50] Cardiac autonomic modulation in polycystic ovary syndrome: does the phenotype matter?
    Di Domenico, Kristhiane
    Wiltgen, Denusa
    Nickel, Fabian J.
    Magalhaes, Jose Antonio
    Moraes, Ruy Silveira
    Spritzer, Poli Mara
    FERTILITY AND STERILITY, 2013, 99 (01) : 286 - 292